Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
Clinical trial NCT07041788 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07041788
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-28
- Primary completion
- 2028-07-09
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.